Evaluation of a rapid optical immunoassay-based test for group B streptococcus colonization in intrapartum patients

References

• Centers for Disease Control and Prevention. Prevention of perinatal Group B streptococcaldisease: a public health perspective. Morbid MortalWeekly Rep 1996;45(RR-7):1–24
   Google Scholar
• AmericanCollege ofObstetriciansand Gynecologists. Prevention of Early-Onset Group B Streptococcal Disease in Newborns, Committee Opinion Number 173. Washington DC: American College of Obstetricians and Gynecologists, 1996:1–8
   Google Scholar
• American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997;99:489–96
   PubMed Web of Science ®Google Scholar
• Prevention of Group B Streptococcal Disease: A Public Health Perspective. Federal Register, December 15, 1994; vol 59, no. 240:64764–73
   Google Scholar
• Weisman LE, Stoll BJ, Cruess DF, Hall RT, Merenstein GB, Hemming VG, et al. Early-onset Group B streptococcalsepsis: a current assessment. J Pediatr 1992;121:428–33
   PubMed Web of Science ®Google Scholar
• Towers CV. Group B streptococcus: the US controversy. Lancet 1995;346:197–9
   Google Scholar
• Regan JA, Klebanoff MA, Nugent RP, for the Vaginal and Prematurity Study Group. The epidemiologyof group B streptococcal colonization in pregnancy. Obstet Gynecol 1991;77:604–10
   PubMed Web of Science ®Google Scholar
• Boyer KM, Gadzala CA, Burd LI, Fisher DE, Paton JB, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis 1983;148:795–801
   PubMed Web of Science ®Google Scholar
• Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665–9
   PubMed Web of Science ®Google Scholar
• Boyer KM, GadzalaCA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartumchemoprophylaxisof neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 1983;148:802–9
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Group B Streptococcal Infections in Pregnancy. Technical Bulletin Number 170. Washington DC: American College of Obstetricians and Gynecologists, 1992
   Google Scholar
• Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV. Comparison of prevention strategies of neonatal group B streptococcal infection. A population-based economic analysis. J Am Med Assoc 1993;270:1442–8
   PubMed Web of Science ®Google Scholar
• Greenspoon JS,Wilcox JG, Kirschbaum TH. GroupB streptococcus: the effectiveness of screening and chemoprophylaxis. Obstet Gynecol Surv 1991;46:499–508
   Google Scholar
• Allen UD, Navas L, King SM. Effectiveness of intrapartum penicillinprophylaxisin preventing early-onsetgroupB streptococcal infection: results of a meta-analysis. Can Med Assoc J 1993;149:1659–65
   Google Scholar
• Strickland DM, Yeomans ER, Hankins GDV. Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization. Am J Obstet Gynecol 1990;163:4–8
   PubMedGoogle Scholar
• Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA Jr. Strategies for the prevention of early-onset group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994;83:483–94
   PubMed Web of Science ®Google Scholar
• Gilbert GL, Isaacs D, Burgess MA,Garland SM, Grimwood K, Hogg GG, et al. Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate? Aust NZ J Obstet Gynaecol 1995;35:120–6
   PubMed Web of Science ®Google Scholar
• Garland SM, Kelly N. Early-onset neonatal group B streptococcalsepsis: economics of variouspreventionstrategies. Med J Aust 1995;162:413–17
   Google Scholar
• Burlington DB. Food and DrugAdministrationSafety Alert: Risks of Devices for Direct Detection of Group B StreptococcalAntigen. Rockville, MD: Department of Health and Human Services, Public Health Service, March 24, 1997
   Google Scholar
• Baker CJ. Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers. Obstet Gynecol1996;88:51–5
   Google Scholar
• Sackett DL, Haynes RB, GuyattGH, Tugwell P. Clinical Epidemiology, A Basic Science for Clinical Medicine, 2nd edn. Boston: Little Brown, 1991:30–1, 55
   Google Scholar
• Ingelfinger JA, Mosteller F, Thiobodeau L, Ware JH. Biostatistics in Clinical Medicine, 2nd edn. London: MacMillan, 1987;2:28–32
   Google Scholar
• McDuffie RS, McGregor JA, Gibbs RS. Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol 1993;82:487–9
   PubMedGoogle Scholar
• Thornsberry C. Emerging resistance in clinically important gram positive bacteria. West J Med 1996;164:28–32
   Google Scholar
• MoralesWJ, Lim D. Reductionof groupBstreptococcalmaternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test. Am J Obstet Gynecol 1987;157:13–16
   Google Scholar
• Reid MC, Lachs MS, Feinstein AR. Use of methodological standard in diagnostic test research: getting better but still not good. J Am Med Assoc 1995;274:645–51
   PubMed Web of Science ®Google Scholar
• Nguyen TM, Gauthier DW, Myles TD, Nuwayhid BS, Viana MG, Screckenberger PC. Detection of group B streptococcus: comparison of an optical immunoassay with direct plating and broth-enhanced culture methods. J Matern Fetal Med 1998;7:172–6
   PubMedGoogle Scholar